Certified by Founder
Lodge
Epoch Biodesign
start up
United Kingdom
- London
- 22/06/2022
- Seed
- $11,000,000
Epoch is the Total BioDesign company developing natural solutions to unnatural problems. We are designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals.
- Industry Biotechnology
- Website https://www.epochbiodesign.com/
- LinkedIn https://www.linkedin.com/company/epochbiodesign/
Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)